A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction

Salaam Semaan, Linda Kay, Darcy Strouse, Ellen Sogolow, Patricia Dolan Mullen, Mary Spink Neumann, Stephen A. Flores, Greet Peersman, Wayne D. Johnson, Paula Darby Lipman, Agatha Eke, Don Des Jarlais

Research output: Contribution to journalArticle

Abstract

We describe 99 (experimental and certain quasi-experimental) U.S.-based trials, reported or published since 1988, of behavioral and social interventions that measured prespecified behavioral and biologic outcomes and aimed to reduce risk for HIV infection. Studies identified through June 1998 by the HIV/AIDS Prevention Research Synthesis project were grouped into 4 risk behavior areas: drug-related (k [number of studies] = 48), heterosexual youth (k = 24), heterosexual adult (k = 17), and same-sex (k = 10). We compared the studies in the 4 areas by variables key to the development, evaluation, and transfer of interventions. Participants comprised injection drug users (43% of studies), drug users out of treatment (29%), African Americans (18%), clinic patients (18%), youth in schools (10%), and drug users in treatment (10%). Most studies were randomized (85%), provided another intervention to the control or comparison groups (71%), and evaluated behavioral interventions (92%). On average, interventions were conducted in 5 sessions (total, 8 hours) during 3 months. The theoretical basis of the intervention was not noted in 57% of the reports. At least one variable from each of the 3 outcome classifications was measured in 8% of the studies: behavioral, biologic, and psychosocial. Distinct profiles exist for the 4 risk areas. Addressing gaps in research and reporting would be helpful for analytical and program activities. This sizable portfolio of evaluated interventions contributes to effectiveness reviews and to considerations of transfer to program practice.

Original languageEnglish (US)
JournalJournal of Acquired Immune Deficiency Syndromes
Volume30
Issue numberSUPPL. 1
DOIs
StatePublished - Jul 1 2002

Fingerprint

Risk Reduction Behavior
Drug Users
Heterosexuality
HIV
Risk-Taking
Research
African Americans
HIV Infections
Acquired Immunodeficiency Syndrome
Injections
Therapeutics
Pharmaceutical Preparations

Keywords

  • Behavior change
  • Drug risk behaviors
  • HIV intervention
  • HIV/AIDS prevention
  • Sex risk behaviors

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)

Cite this

A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. / Semaan, Salaam; Kay, Linda; Strouse, Darcy; Sogolow, Ellen; Mullen, Patricia Dolan; Neumann, Mary Spink; Flores, Stephen A.; Peersman, Greet; Johnson, Wayne D.; Lipman, Paula Darby; Eke, Agatha; Des Jarlais, Don.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 30, No. SUPPL. 1, 01.07.2002.

Research output: Contribution to journalArticle

Semaan, S, Kay, L, Strouse, D, Sogolow, E, Mullen, PD, Neumann, MS, Flores, SA, Peersman, G, Johnson, WD, Lipman, PD, Eke, A & Des Jarlais, D 2002, 'A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction', Journal of Acquired Immune Deficiency Syndromes, vol. 30, no. SUPPL. 1. https://doi.org/10.1097/00042560-200207011-00004
Semaan, Salaam ; Kay, Linda ; Strouse, Darcy ; Sogolow, Ellen ; Mullen, Patricia Dolan ; Neumann, Mary Spink ; Flores, Stephen A. ; Peersman, Greet ; Johnson, Wayne D. ; Lipman, Paula Darby ; Eke, Agatha ; Des Jarlais, Don. / A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction. In: Journal of Acquired Immune Deficiency Syndromes. 2002 ; Vol. 30, No. SUPPL. 1.
@article{4302a43f431f42e48c34c9f298ba32a6,
title = "A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction",
abstract = "We describe 99 (experimental and certain quasi-experimental) U.S.-based trials, reported or published since 1988, of behavioral and social interventions that measured prespecified behavioral and biologic outcomes and aimed to reduce risk for HIV infection. Studies identified through June 1998 by the HIV/AIDS Prevention Research Synthesis project were grouped into 4 risk behavior areas: drug-related (k [number of studies] = 48), heterosexual youth (k = 24), heterosexual adult (k = 17), and same-sex (k = 10). We compared the studies in the 4 areas by variables key to the development, evaluation, and transfer of interventions. Participants comprised injection drug users (43{\%} of studies), drug users out of treatment (29{\%}), African Americans (18{\%}), clinic patients (18{\%}), youth in schools (10{\%}), and drug users in treatment (10{\%}). Most studies were randomized (85{\%}), provided another intervention to the control or comparison groups (71{\%}), and evaluated behavioral interventions (92{\%}). On average, interventions were conducted in 5 sessions (total, 8 hours) during 3 months. The theoretical basis of the intervention was not noted in 57{\%} of the reports. At least one variable from each of the 3 outcome classifications was measured in 8{\%} of the studies: behavioral, biologic, and psychosocial. Distinct profiles exist for the 4 risk areas. Addressing gaps in research and reporting would be helpful for analytical and program activities. This sizable portfolio of evaluated interventions contributes to effectiveness reviews and to considerations of transfer to program practice.",
keywords = "Behavior change, Drug risk behaviors, HIV intervention, HIV/AIDS prevention, Sex risk behaviors",
author = "Salaam Semaan and Linda Kay and Darcy Strouse and Ellen Sogolow and Mullen, {Patricia Dolan} and Neumann, {Mary Spink} and Flores, {Stephen A.} and Greet Peersman and Johnson, {Wayne D.} and Lipman, {Paula Darby} and Agatha Eke and {Des Jarlais}, Don",
year = "2002",
month = "7",
day = "1",
doi = "10.1097/00042560-200207011-00004",
language = "English (US)",
volume = "30",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - A profile of U.S.-based trials of behavioral and social interventions for HIV risk reduction

AU - Semaan, Salaam

AU - Kay, Linda

AU - Strouse, Darcy

AU - Sogolow, Ellen

AU - Mullen, Patricia Dolan

AU - Neumann, Mary Spink

AU - Flores, Stephen A.

AU - Peersman, Greet

AU - Johnson, Wayne D.

AU - Lipman, Paula Darby

AU - Eke, Agatha

AU - Des Jarlais, Don

PY - 2002/7/1

Y1 - 2002/7/1

N2 - We describe 99 (experimental and certain quasi-experimental) U.S.-based trials, reported or published since 1988, of behavioral and social interventions that measured prespecified behavioral and biologic outcomes and aimed to reduce risk for HIV infection. Studies identified through June 1998 by the HIV/AIDS Prevention Research Synthesis project were grouped into 4 risk behavior areas: drug-related (k [number of studies] = 48), heterosexual youth (k = 24), heterosexual adult (k = 17), and same-sex (k = 10). We compared the studies in the 4 areas by variables key to the development, evaluation, and transfer of interventions. Participants comprised injection drug users (43% of studies), drug users out of treatment (29%), African Americans (18%), clinic patients (18%), youth in schools (10%), and drug users in treatment (10%). Most studies were randomized (85%), provided another intervention to the control or comparison groups (71%), and evaluated behavioral interventions (92%). On average, interventions were conducted in 5 sessions (total, 8 hours) during 3 months. The theoretical basis of the intervention was not noted in 57% of the reports. At least one variable from each of the 3 outcome classifications was measured in 8% of the studies: behavioral, biologic, and psychosocial. Distinct profiles exist for the 4 risk areas. Addressing gaps in research and reporting would be helpful for analytical and program activities. This sizable portfolio of evaluated interventions contributes to effectiveness reviews and to considerations of transfer to program practice.

AB - We describe 99 (experimental and certain quasi-experimental) U.S.-based trials, reported or published since 1988, of behavioral and social interventions that measured prespecified behavioral and biologic outcomes and aimed to reduce risk for HIV infection. Studies identified through June 1998 by the HIV/AIDS Prevention Research Synthesis project were grouped into 4 risk behavior areas: drug-related (k [number of studies] = 48), heterosexual youth (k = 24), heterosexual adult (k = 17), and same-sex (k = 10). We compared the studies in the 4 areas by variables key to the development, evaluation, and transfer of interventions. Participants comprised injection drug users (43% of studies), drug users out of treatment (29%), African Americans (18%), clinic patients (18%), youth in schools (10%), and drug users in treatment (10%). Most studies were randomized (85%), provided another intervention to the control or comparison groups (71%), and evaluated behavioral interventions (92%). On average, interventions were conducted in 5 sessions (total, 8 hours) during 3 months. The theoretical basis of the intervention was not noted in 57% of the reports. At least one variable from each of the 3 outcome classifications was measured in 8% of the studies: behavioral, biologic, and psychosocial. Distinct profiles exist for the 4 risk areas. Addressing gaps in research and reporting would be helpful for analytical and program activities. This sizable portfolio of evaluated interventions contributes to effectiveness reviews and to considerations of transfer to program practice.

KW - Behavior change

KW - Drug risk behaviors

KW - HIV intervention

KW - HIV/AIDS prevention

KW - Sex risk behaviors

UR - http://www.scopus.com/inward/record.url?scp=17744413689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744413689&partnerID=8YFLogxK

U2 - 10.1097/00042560-200207011-00004

DO - 10.1097/00042560-200207011-00004

M3 - Article

VL - 30

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - SUPPL. 1

ER -